首页> 外国专利> ARSENIC SPECIATION AND METALLOMICS PROFILING-BASED NAIL BIOMARKERS FOR CANCER DIAGNOSIS AND PROGNOSIS

ARSENIC SPECIATION AND METALLOMICS PROFILING-BASED NAIL BIOMARKERS FOR CANCER DIAGNOSIS AND PROGNOSIS

机译:基于砷形态学和金属学特征的指甲生物标志物用于癌症的诊断和预后

摘要

The invention provides a non-invasive arsenic speciation and metallomics-basednailbiomarkers of chronic disease outcomes including cancers associated witharsenic andtoxic metal exposures and the methods for cancer diagnosis and prognosis usingthesebiomarkers. The biomarkers are proportions and ratios of several arsenicspecies andother metal profiles measured in biological nail samples. Metallomics is thecomprehensive analysis of the entirety of metal species within a biologicalspecimen.Our invention has demonstrated for the first time that the proportions ofarsenic speciesin human nails are associated with chronic disease including cancers anddifferbetween individuals with and without chronic disease including cancers. Thus,analysisof arsenic species combined with other interacting metals (such as selenium)inbiological nail samples can be used to monitor an individual's exposuresrelated tohealth and chronic disease outcomes, and to quantify an individual's cancerrisk,diagnosis and prognosis.Chronic exposure to toxic metals including arsenic has been linked to a numberofhuman diseases affecting multiple organ systems, including several cancers,diabetes,and cardiovascular and neurological disease. Most cases assessing canceroutcomesassociated with arsenic exposure have used on analysis of urine, in whicharsenic has ashort residence time (3 - 4 days), and which is thus better suited forassessing short-term,acute exposure. Since many arsenic-related cancers arise from chronic exposureand can develop over the course of several years, measuring longer-termbiomarkersmay prove to be a more relevant assessment. To the best of our knowledge, thisis thefirst invention for indicating exposures related to chronic disease outcomes,diseaserisk, disease presence, and disease prognosis, specifically related to chronicdiseaseincluding skin, lung, bladder, and kidney cancer, and type II diabetes.To the best of our knowledge, this is the first large study investigating theassociationsbetween arsenic exposure and various cancers using toenail arsenic speciationanalysis, a potentially important, more relevant biomarker for chronicdiseases.Toenails have been shown to be more reliable as markers of long-term exposurethanhair or fingernails, as they are less prone to contamination and washouteffects fromthings such as shampoo, nail polish, or regular handling of items
机译:本发明提供了一种非侵入性的砷形态学和基于冶金学的方法钉慢性疾病预后的生物标志物,包括与癌症有关的癌症砷和有毒金属暴露以及使用该方法进行癌症诊断和预后的方法这些生物标志物。生物标志物是几种砷的比例和比率种类和在生物指甲样本中测量的其他金属轮廓。冶金学是对生物中整个金属种类的全面分析标本。我们的发明首次证明了砷类在人类指甲中与慢性疾病有关,包括癌症和不同患有或不患有包括癌症在内的慢性疾病的个体之间的关系。从而,分析与其他相互作用金属(例如硒)结合的砷物种在生物指甲样本可用于监测个人的暴露情况相关健康和慢性疾病结局,以及量化个人的癌症风险,诊断和预后。长期接触包括砷在内的有毒金属与许多原因有关的影响多种器官系统的人类疾病,包括几种癌症,糖尿病,以及心血管和神经疾病。大多数评估癌症的病例结果与砷接触有关的物质已用于尿液分析,其中砷有一个停留时间短(3-4天),因此更适合短期评估急性暴露。由于许多砷相关的癌症是由于长期暴露引起的并且可以在数年的时间里发展,可以长期衡量生物标志物可能被证明是更相关的评估。据我们所知,是个用于指示与慢性疾病预后相关的暴露的第一项发明,疾病风险,疾病的存在和疾病的预后,尤其与慢性疾病包括皮肤癌,肺癌,膀胱癌和肾癌,以及II型糖尿病。据我们所知,这是第一个大型研究协会趾甲砷形态学研究砷暴露与各种癌症之间的关系分析,对于慢性病可能是潜在的,更相关的生物标志物疾病。脚趾甲已被证明是长期暴露的可靠标志比头发或指甲,因为它们不易被污染和冲洗来自的影响诸如洗发水,指甲油或常规处理物品之类的东西

著录项

  • 公开/公告号CA3007403A1

    专利类型

  • 公开/公告日2019-11-23

    原文格式PDF

  • 申请/专利权人 KIM JONG SUNG;JO YONG MIN YMJ;

    申请/专利号CA20183007403

  • 发明设计人 KIM JONG SUNG;JO YONG MIN YMJ;

    申请日2018-06-06

  • 分类号G01N33/48;

  • 国家 CA

  • 入库时间 2022-08-21 11:14:52

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号